Prophylactic effect of phenytoin in bipolar disorder: A controlled study

A. Mishory, M. Winokur, Yuly Bersudsky

    Research output: Contribution to journalReview articlepeer-review

    44 Scopus citations


    Objective: Phenytoin is an effective anticonvulsant that has not previously been studied prophylactically in bipolar (BP) patients. Thus a study of phenytoin prophylaxis was undertaken and is herein reported. Method: Bipolar patients were studied who had at least one episode per year in the previous 2 years despite ongoing prophylaxis. Patients were stable for a mean of 4 months (range 1-13) before entering the study. Phenytoin or placebo was added to their current therapy in a double-blind cross-over design for 6 months in each phase. Thirty observation periods of 6 months each were studied for 23 patients. Results: Three patients had relapse on phenytoin and nine had relapse on placebo. There was a significant prophylactic effect of phenytoin in BP disorder [Cox's F-test for comparing survival in two groups: F(6, 18) = 3.44, p = 0.02]. Conclusions: This study suggests prophylactic effects of add-on phenytoin in BP illness. However, the number of patients was small and confirmation is necessary.

    Original languageEnglish
    Pages (from-to)464-467
    Number of pages4
    JournalBipolar Disorders
    Issue number6
    StatePublished - 1 Dec 2003


    • Bipolar disorder
    • Phenytoin
    • Prophylactic

    ASJC Scopus subject areas

    • Psychiatry and Mental health
    • Biological Psychiatry


    Dive into the research topics of 'Prophylactic effect of phenytoin in bipolar disorder: A controlled study'. Together they form a unique fingerprint.

    Cite this